(Q39200752)

English

Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in the Gambia

scientific article published on 11 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in the Gambia (English)

1 reference

Europe PubMed Central

9 September 2017

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

Brian Greenwood

7

object named as

Brian Greenwood

1 reference

Europe PubMed Central

9 September 2017

4

object named as

David Jeffries

1 reference

Europe PubMed Central

9 September 2017

author name string

Grant A Mackenzie

1

1 reference

Europe PubMed Central

9 September 2017

Christian Bottomley

2

1 reference

Europe PubMed Central

9 September 2017

Albert J van Hoek

3

1 reference

Europe PubMed Central

9 September 2017

Martin Ota

5

1 reference

Europe PubMed Central

9 September 2017

Syed M A Zaman

6

1 reference

Europe PubMed Central

9 September 2017

Felicity Cutts

8

1 reference

Europe PubMed Central

9 September 2017

language of work or name

0 references

publication date

11 March 2014

1 reference

Europe PubMed Central

9 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

9 September 2017

32

1 reference

Europe PubMed Central

9 September 2017

21

1 reference

Europe PubMed Central

9 September 2017

2493-2500

1 reference

Europe PubMed Central

9 September 2017

randomized experiment

0 references

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.081

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.02.081

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39200752&oldid=1812802190"